Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.

Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.

Item
http://www.wikidata.org/entity/Q39264721
SNAP-23 and VAMP-3 contribute to the release of IL-6 and TNFα from a human synovial sarcoma cell lineTNFα induces co-trafficking of TRPV1/TRPA1 in VAMP1-containing vesicles to the plasmalemma via Munc18-1/syntaxin1/SNAP-25 mediated fusion.Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virusHolotoxin Activity of Botulinum Neurotoxin Subtype A4 Originating from a Nontoxigenic Clostridium botulinum Expression System.Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behaviorNovel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014).Synthetic self-assembling clostridial chimera for modulation of sensory functions.Neuronal entry and high neurotoxicity of botulinum neurotoxin A require its N-terminal binding sub-domainBotulinum Neurotoxin Subtype A4 Originating from Nontoxigenic Clostridium botulinum.Targeted delivery of a SNARE protease to sensory neurons using a single chain antibody (scFv) against the extracellular domain of P2X(3) inhibits the release of a pain mediator.Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin.
P2860

Novel therapeutics based on recombinant botulinum neurotoxins to normalize the release of transmitters and pain mediators.

Item
http://www.wikidata.org/entity/Q39264721
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Novel therapeutics based on re ...... ansmitters and pain mediators.
@en
Novel therapeutics based on re ...... ansmitters and pain mediators.
@nl
type
label
Novel therapeutics based on re ...... ansmitters and pain mediators.
@en
Novel therapeutics based on re ...... ansmitters and pain mediators.
@nl
prefLabel
Novel therapeutics based on re ...... ansmitters and pain mediators.
@en
Novel therapeutics based on re ...... ansmitters and pain mediators.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Novel therapeutics based on re ...... ansmitters and pain mediators.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1742-4658.2011.08205.X
P407
P433
P478
P50
P577
P5875
P698